Ventas, Inc. $VTR Shares Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. raised its holdings in Ventas, Inc. (NYSE:VTR) by 10.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,099 shares of the real estate investment trust’s stock after buying an additional 8,358 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Ventas were worth $6,026,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. NewEdge Advisors LLC lifted its holdings in shares of Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after purchasing an additional 7,097 shares during the last quarter. Empowered Funds LLC increased its position in Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after buying an additional 536 shares during the period. Woodline Partners LP lifted its stake in Ventas by 46.8% in the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares during the last quarter. Focus Partners Wealth boosted its holdings in shares of Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares during the period. Finally, J. Safra Sarasin Holding AG purchased a new position in shares of Ventas during the second quarter worth approximately $1,847,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Price Performance

Ventas stock opened at $77.65 on Friday. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.32 and a current ratio of 0.32. Ventas, Inc. has a one year low of $58.72 and a one year high of $81.89. The company has a market cap of $36.48 billion, a P/E ratio of 149.33, a price-to-earnings-growth ratio of 1.90 and a beta of 0.78. The business has a fifty day moving average of $78.20 and a two-hundred day moving average of $72.78.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.01. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter last year, the firm posted $0.80 EPS. The business’s revenue was up 20.5% compared to the same quarter last year. As a group, analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Wednesday, December 31st were issued a $0.48 dividend. The ex-dividend date was Wednesday, December 31st. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s dividend payout ratio is currently 369.23%.

Insider Activity at Ventas

In related news, CEO Debra A. Cafaro sold 41,294 shares of Ventas stock in a transaction on Monday, November 17th. The stock was sold at an average price of $79.01, for a total transaction of $3,262,638.94. Following the completion of the transaction, the chief executive officer directly owned 1,145,695 shares of the company’s stock, valued at approximately $90,521,361.95. The trade was a 3.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Peter J. Bulgarelli sold 3,924 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $75.00, for a total value of $294,300.00. Following the completion of the sale, the chief executive officer directly owned 112,564 shares in the company, valued at $8,442,300. This trade represents a 3.37% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 176,747 shares of company stock valued at $13,579,533 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on VTR. Scotiabank lifted their price objective on shares of Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a research note on Thursday, November 13th. KeyCorp boosted their price target on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. The Goldman Sachs Group started coverage on Ventas in a research note on Friday, January 9th. They set a “buy” rating and a $94.00 price objective for the company. Citigroup lifted their target price on Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research note on Tuesday, November 11th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $93.00 price target on shares of Ventas in a research note on Monday, January 5th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and an average target price of $81.63.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.